A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation. Front, Psychiatry, vol.4, 2014. ,
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review, Cognit. Neuropsychiatry, vol.18, pp.44-82, 2013. ,
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.16720-16725, 2012. ,
Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome, International 22q11.2DS Brain and Behavior Consortium, 2017. ,
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene, Biol. Psychiatry, vol.86, pp.523-535, 2019. ,
Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?, Schizophr. Bull, vol.40, pp.744-755, 2014. ,
Generalized and Specific Cognitive Performance in Clinical High-Risk Cohorts: A Review Highlighting Potential Vulnerability Markers for Psychosis, Schizophr. Bull, vol.32, pp.538-555, 2006. ,
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis, Psychiatry Res, vol.230, pp.878-884, 2015. ,
From the psychosis prodrome to the firstepisode of psychosis: No evidence of a cognitive decline, J. Psychiatr. Res, vol.96, pp.231-238, 2018. ,
In vivo gamma-aminobutyric acid and glutamate levels in people with firstepisode schizophrenia: A proton magnetic resonance spectroscopy study, Schizophr. Res, 2017. ,
Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development, J. Psychiatry Neurosci. JPN, vol.34, pp.450-458, 2009. ,
A prospective analysis of the role of cognition in three models of aging and schizophrenia, Schizophr. Res, 2017. ,
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder, Nat. Genet, vol.44, pp.78-84, 2011. ,
Cognitive functioning in prodromal psychosis: a metaanalysis, Arch. Gen. Psychiatry, vol.69, pp.562-571, 2012. ,
Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis, Psychiatry Res, vol.242, pp.157-162, 2016. ,
Cognition in schizophrenia: Past, present, and future, Schizophr. Res. Cogn, vol.1, pp.1-9, 2014. ,
Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort, Eur. Psychiatry, vol.45, pp.50-58, 1966. ,
Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia -An observational 9-year follow-up study, Schizophr. Res, vol.158, pp.134-141, 2014. ,
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of doubleblind randomized controlled trials, Mol. Psychiatry, vol.20, pp.1151-1160, 2015. ,
Early intervention for psychosis: a Canadian perspective, J. Nerv. Ment. Dis, vol.203, pp.356-364, 2015. ,
, Nat. Rev. Dis. Primer, vol.15067, 2015.
Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder, Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet, vol.165, pp.365-372, 2014. ,
High dose D-serine in the treatment of schizophrenia, Schizophr. Res, vol.121, pp.125-130, 2010. ,
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial, Lancet Psychiatry, vol.2, pp.403-412, 2015. ,
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia, Schizophr. Res, vol.132, pp.220-227, 2011. ,
In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T, Biol. Psychiatry, 2017. ,
, , 2014.
, , vol.40, pp.447-456
Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial, Biol. Psychiatry, vol.39, pp.585-589, 1996. ,
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the, Cognitive Genomics consorTium (COGENT). Mol. Psychiatry, vol.19, pp.168-174, 2014. ,
Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.26, pp.136-146, 2016. ,
Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia, Transl. Psychiatry, vol.10, 2020. ,
Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder, Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet, vol.168, pp.258-264, 2015. ,
Subjects at Ultra High Risk for psychosis have "heterogeneous" intellectual functioning profile: a multiple-case study, Schizophr. Res, vol.152, pp.415-420, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01312814
Neuropsychology of subjects with ultra-high risk (UHR) of psychosis: A critical analysis of the literature, L'Encephale, vol.43, pp.241-253, 2017. ,
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia, Neurosci. Biobehav. Rev, vol.37, pp.256-268, 2013. ,
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies, JAMA Psychiatry, vol.73, pp.665-674, 2016. ,
Altering the course of schizophrenia: progress and perspectives, Nat. Rev. Drug Discov, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01936376
The early longitudinal course of cognitive deficits in schizophrenia, J. Clin. Psychiatry, vol.75, issue.2, pp.25-29, 2014. ,
The C'JAAD: a French team for early intervention in psychosis in Paris, Early Interv. Psychiatry, 2016. ,
, Lancet Lond. Engl, vol.388, pp.1121-1127, 2016.
Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction, Schizophr. Bull, vol.42, pp.415-424, 2016. ,
The new genetics of intelligence, Nat. Rev. Genet, vol.19, pp.148-159, 2018. ,
Diagnostic Yield and Novel Candidate Genes by Exome Sequencing in 152 Consanguineous Families With Neurodevelopmental Disorders, JAMA Psychiatry, vol.74, pp.293-299, 2017. ,
The GRM7 gene, early response to risperidone, and schizophrenia: a genomewide association study and a confirmatory pharmacogenetic analysis, Pharmacogenomics J, vol.17, pp.146-154, 2017. ,
Genetic identification of brain cell types underlying schizophrenia, Nat. Genet, vol.50, pp.825-833, 2018. ,
, NeuroCHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology
, Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function, JAMA Psychiatry, 2017.
Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence, Nat. Genet, vol.49, pp.1107-1112, 2017. ,
Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism, Schizophr. Res, vol.202, pp.106-110, 2018. ,
Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia, Pharmacogenomics, vol.15, pp.925-932, 2014. ,
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes, Transl. Psychiatry, vol.6, 2016. ,
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia, Transl. Psychiatry, vol.1, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01133889
The influence of the glutamatergic system on cognition in schizophrenia: A systematic review, Neurosci. Biobehav. Rev, vol.77, pp.369-387, 2017. ,
Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples, Arch. Gen. Psychiatry, vol.64, pp.1348-1355, 2007. ,
Confidence and psychosis: a neurocomputational account of contingency learning disruption by NMDA blockade, Mol. Psychiatry, vol.21, pp.946-955, 2016. ,
, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, vol.447, pp.661-678, 2007.
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP. Stem Cell Rep, vol.4, pp.795-810, 2015. ,
A review of molecular genetic studies of neurocognitive deficits in schizophrenia, Neurosci. Biobehav. Rev, vol.72, pp.50-67, 2017. ,
SCAN database: facilitating integrative analyses of cytosine modification and expression QTL, Database J. Biol. Databases Curation, 2015. ,